$0.9800
0.04524.84%
Last update: Nov 3, 4:02 PM
NeuroOne Medical Technologies Corp
NMTCNASDAQ
NeuroOne Medical Tech (NMTC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
NeuroOne Medical Tech (NMTC) last issued guidance on October 5, 2026 for fiscal year 2026. The company guided revenue in the range of $10.5M - $10.5M for the period.
Compared to prior guidance, NeuroOne Medical Tech raised its revenue forecast from a prior range of $3.8M - $3.8M.
NeuroOne Medical Tech has issued 8 guidance updates between January 3, 2025 and October 5, 2026. During this period, the company raised its outlook 1 time and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.22 | $-0.23 | $-0.24 | $-0.24 |
| Actual | $-0.28 | $-0.25 | $-0.18 | $-0.24 |
| Surprise | -27.3% | -8.70% | +25.0% | 0.00% |
| Revenue | ||||
| Estimate | $2.5M | $2.6M | $2.7M | $2.5M |
| Actual | $2.0M | $2.4M | $2.9M | $2.7M |
| Surprise | -22.6% | -7.19% | +8.84% | +11.0% |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.19 | $-0.17 |
| Revenue | ||
| Consensus | $3.8M | $3.3M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Aug 13, 2026 | $-0.28 | $-0.22 | -27.3 % |
| Q2 | May 12, 2026 | $-0.25 | $-0.23 | -8.70 % |
| Q1 | Feb 17, 2026 | $-0.18 | $-0.24 | 25.0 % |
| Q4 | Dec 17, 2025 | $-0.24 | $-0.24 | 0.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Aug 13, 2026 | $1.97M | $2.55M | -22.6 % |
| Q2 | May 12, 2026 | $2.39M | $2.58M | -7.19 % |
| Q1 | Feb 17, 2026 | $2.89M | $2.66M | 8.84 % |
| Q4 | Dec 17, 2025 | $2.74M | $2.47M | 11.0 % |
